Your browser doesn't support javascript.
loading
Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection Methods.
Schats, Kelly A; Van Vré, Emily A; Boeckx, Carolien; De Bie, Martine; Schrijvers, Dorien M; Neyns, Bart; De Meester, Ingrid; Kockx, Mark M.
Affiliation
  • Kockx MM; From the Departments of Immunohistochemistry (Drs Schats, Van Vré, Boeckx, and Schrijvers and Ms De Bie) and Molecular Pathology (Dr Kockx), HistoGeneX, Antwerp, Belgium; the Department of Medical Biochemistry, University of Antwerp, Antwerp, Belgium (Drs Schats and De Meester); and the Department of Medical Oncology, Universitair Ziekenhuis Brussel, Belgium (Dr Neyns).
Arch Pathol Lab Med ; 142(8): 982-991, 2018 08.
Article in En | MEDLINE | ID: mdl-29607663

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reagent Kits, Diagnostic / Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / B7-H1 Antigen / Lung Neoplasms / Melanoma Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limits: Humans Language: En Journal: Arch Pathol Lab Med Year: 2018 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Reagent Kits, Diagnostic / Biomarkers, Tumor / Carcinoma, Non-Small-Cell Lung / B7-H1 Antigen / Lung Neoplasms / Melanoma Type of study: Diagnostic_studies / Evaluation_studies / Prognostic_studies Limits: Humans Language: En Journal: Arch Pathol Lab Med Year: 2018 Type: Article